Papers/PMID:37217800
The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.
Scientific reports2023The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
acrylamide — no detected effect on type 2 diabetes incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Acrylamide intake was positively associated with the incidence of T2D in model 1 (P for trend = 0.009); however, our results showed no association in model 2 after adjusting for confounding variables.”
Quoted verbatim from The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.. - Study
- cohort
- Population
- 6022 adults (2707 men, 3315 women) free of diabetes at baseline in the Tehran Lipid and Glucose Study, dietary acrylamide intake by quartile, median follow-up 6.63 years; whole-cohort result
The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.2023PMID:37217800Permalink